Upper Body Subcutaneous Exosome Release in Response to a Meal in Obesity
Part of paid clinical trials in Rochester, Minnesota.
- Sponsor
- Mayo Clinic
- Study ID
- NCT07031297
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 55 Years
- Healthy Volunteers
- Accepted
Interventions
- Meal Study — DIAGNOSTIC_TESTParticipants will consume a mixed meal drink (Ensure) equivalent to 40% of basil metabolic rate as calculated via Harris Benedict equation. Following consumption of the drink they will undergo a series of blood draws over the following 4 hours: * Plasma glucose will be measured according to a mixed meal test protocol every 10 minutes for the first hour and then every 15, then 30 minutes for the last 3 hours. * 1 ml plasma aliquots for exosome analysis and insulin concentrations will be drawn every 30 minutes following consumption of ensure for 4 hours. * Blood gasses will be drawn every 30 minutes for the 4 hours following the meal. Participants will undergo a second abdominal adipose tissue biopsy 3 hours following mixed meal drink.
Study Details
The purpose of this study is to understand the specific outflow and difference between normal weight and volunteers with obesity of upper body subcutaneous adipose tissue in response to a mixed meal challenge by site specific cannulation of the superior epigastric vein. We will characterize the exosome signatures in response to a meal and compare to the exosome signature of arterialized venous plasma samples.
Key Dates
- First listed
- Jun 22, 2025
- Start date
- May 5, 2026
- Status verified
- Jul 2026
- Primary completion
- May 31, 2028
- Completion
- May 31, 2028
Study Design
- Enrollment
- 20 participants (estimated)
- Allocation
- NON_RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- BASIC_SCIENCE
Arms
- Other: Normal weight group5 male and 5 female volunteers in normal weight range
- Other: Obesity group5 male and 5 female volunteers with obesity (BMI 29.0-35.0 kg/m2)
Primary Outcome Measure
Adipose tissue blood flow [ Time Frame: 4 hours ]
Central Contacts
- Kelli A. Lytle, Ph.D.507-255-1488
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Mayo Clinic in Rochester | Rochester | Minnesota | 55905 | Kelli A Lytle (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Rochester, MN
By condition
By specialty
By research site
Related Studies
- Insulin Regulation of Lipolysis and Lipolysis ProteinsEARLY_PHASE1 · Recruiting · Mayo Clinic · Rochester, Minnesota
- Evaluating Benefit of Peptide Based Diet in Obese HEN PatientsEnrolling By Invitation · Mayo Clinic · Rochester, Minnesota
- Caloric Restriction and Activity to Reduce Chemoresistance in B-ALLPHASE2 · Recruiting · Etan Orgel · Los Angeles, California
- tDCS With Cognitive Training to Reduce Impulsivity and Weight in Veterans With ObesityRecruiting · VA Office of Research and Development · Minneapolis, Minnesota